Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly

MeSH terms

• Clinical Trials as Topic
• Drug Approval
• Drug Industry* / economics
• Humans
• Marketing*
• Practice Guidelines as Topic*
• Protein C / adverse effects
• Protein C / therapeutic use*
• Recombinant Proteins / adverse effects
• Recombinant Proteins / therapeutic use
• Research Support as Topic
• Sepsis / drug therapy*
• United States
• United States Food and Drug Administration